In The Spotlight


basi1-nov05.jpg Shares of Bioanalytical Systems Inc. (BASI), which closed at a new 52-week high of $5.33 yesterday, are up over 300 percent year-to-date.

biotechipo-july19.jpg The IPO activity in the U.S. healthcare sector has had a strong showing so far in the last quarter of the year, with 12 listings in the month of October alone.

mirum-nov01.jpg Shares of Mirum Pharmaceuticals Inc. (MIRM) are down nearly 46% since their market debut on July 18, 2019.

biotechipo-jun14.jpg The U.S. healthcare sector has witnessed 11 IPOs so far this month. Let's take a look at what's in store for the week ahead.

phathom-oct23.jpg Phathom Pharmaceuticals Inc., a late clinical-stage biopharmaceutical company developing treatments for gastrointestinal diseases, is all set to list its common stock on the Nasdaq Global Market under the symbol "PHAT" on October 25, 2019.

zynex-oct22.jpg Shares of Zynex Inc. (ZYXI) which touched an all-time intraday high of $13.10 on October 7, 2019, a gain of a whopping 345 percent year-to-date, have given back some of the gains and trade around $10.

biotechipo-july19.jpg The following companies belonging to the healthcare sector are slated to debut on the U.S. public market in the week ahead. 1. Happiness Biotech Group Ltd China-based Happiness Biotech Group Limited is a nutraceutical and dietary supplements producer, developing a variety of products made from...

zeiss-oct17.jpg Shares of Carl Zeiss Meditec AG (AFX.F) are up 52 percent year-to-date on the Frankfurt Stock Exchange while the German benchmark index, the DAX, has gained 20 percent for the same period.

melinta1-oct15.jpg Melinta Therapeutics Inc. (MLNT), which has gained 59 percent over the last two months, awaits a regulatory catalyst next week.

biofrontera-oct14.jpg Shares of Biofrontera AG (B8F.F) (BFRA) are currently down 5.61% on the Frankfurt Stock Exchange, trading at EUR 5.05.

biotechipo-jun14.jpg Marseille, France-based Innate Pharma S.A., is a biotechnology company developing therapeutic antibodies for the treatment of oncology indications with unmet medical need.

4sc-oct09.jpg Shares of Germany-based 4SC AG (VSE), which trade on the Frankfurt Stock Exchange, have gained 7 percent over the last seven trading days.

biotechipo-jun14.jpg We are just one week into the fourth quarter of the year. The week that just wrapped up saw 3 biotech companies making their public debut, and one company, ADC Therapeutics, withdrawing its IPO filing, citing adverse market conditions.

evofem-oct04.jpg Shares of Evofem Biosciences Inc. (EVFM) are up 22 percent year-to-date while the iShares Nasdaq Biotechnology ETF (IBB), a bellwether of investor sentiment, has gained only 2.5 percent for the same period.

biotechipo-jun14.jpg The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 46 listings in the 9-month period of the year and 12 listings in the third quarter.

Follow RTT